top of page

Advances in subcutaneous infusion pump therapy for PAH

Aug 24
1 min read

Infusion pump technology for subcutaneous prostacyclin analog therapy has improved, with improved user experiences, simplified priming processes, easier filling, capability for lower doses, and better safety alerts and alarms. This may allow more pulmonary arterial hypertension (PAH) patients to safely manage and benefit from subcutaneous prostacyclin analogs.


 
 
 

Recent Posts

What affects physical activity for people with PH?

A UK study examined the factors that affected physical activity participation among people with pulmonary hypertension (PH). They found four themes: fear of breathlessness; lack of motivation and a de

 
 
 

2 Comments


Great to see pump tech getting easier for PAH patients—makes life simpler. Speaking of simplifying complex things, I love using Chess Analysis to unpack tricky moves and improve my game. Both are about making hard tasks more manageable!

Like

Abbey Lee
Sep 19

Been using Pico Image for a while now for resizing and compressing images. It runs entirely in the browser so nothing gets uploaded to a server, which I find reassuring. Background removal works pretty well too, saves me from opening heavier software for simple tasks.

Like

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page